2018 Aug 2018 Sep 2018 Oct 2018 Nov 2018 Dec 2018 Jan 2019 Feb 2019 Mar 2019 Apr 2019 May 2019 Milestones / action items: n Database development and testing n Pilot test questionnaire n Analyze pilot data and identify potential logistical and feasibility issues n Develop a knowledge transfer plan Milestones / action items: n Analyze survey data and generate reports n Analyze systematic review and generate reports n Write technical report n Subject reports to internal peer review (steering committee) n Subject reports to external peer review (steering committee) n Prepare and submit a scientific paper n Edit and publish technical report Milestones / action items: n Identify key stakeholders and partners; establish steering committee n Contact specific national and regional stakeholders n Finish reviewing questionnaires n Finalize protocol and translations n Begin desk research phase Milestones / action items: n Administer main survey n Send out reminders and follow up with key contacts n Develop database and analyze survey data n Perform follow-up interviews with ISN regional leaders n Complete literature search and data extraction for the desk research phase n Perform an internal review of the collated data (steering committee and ISN leadership) ISN Global Kidney Health Atlas | 2019 Methods | 29 Building blocks Indicators/metrics Data sources Essential elements Country profile ®Total population (millions) ®Gross national income per capita ®Literature reviews ®Demographic and economic characteristics Health service delivery ®Description of healthcare system: public/private health insurance funded by national taxation/income contributions covering all/a proportion of the population; ratio of public/private MDs, renal care centers and/or HD centers. ®Literature reviews ®Surveys ®Interviews ®Comprehensiveness ®Accessibility ®Coverage ®Quality ®Coordination ®Efficiency ®Accountability Health workforce ®Density of physicians (per 10,000 population) ®Density of nursing and midwifery personnel (per 10,000 population) ®Density of pharmaceutical personnel (per 10,000 population) ®Literature reviews ®Surveys ®Interviews ®WHO Global Observatory ®Reach and distribution ®Accessibility Health information systems ®Health information system performance index ®Literature reviews ®Surveys ®Interviews ®Reach ®Scope ®Comprehensiveness Essential medicines and technologies ®Median availability of selected generic medicines in public and private sectors (%) ®Median consumer price ratio of selected generic medicines in public and private sectors ®Literature reviews ®Surveys ®Interviews ®WHO Global Observatory ®Equitable access ®Quality and safety ®Cost-effectiveness Health financing ®Total expenditure on health as a percentage of GDP ®General government expenditure on health as a percentage of total expenditure on health ®Private expenditure on health as a percentage of total expenditure on health ®General government expenditure on health as a percentage of total government expenditure ®Out-of-pocket expenditure as a percentage of private expenditure on health ®Private prepaid plans as a percentage of private expenditure on health ®Literature reviews ®WHO Global Observatory ®Database ®Availability of funds ®Extent of financial risk protection Leadership and governance (national policies and frameworks) ®National non-communicable chronic disease policy (where it exists): overarching disease policy targeting long term conditions including CVD, diabetes, cancer, CKD, etc. ®Literature reviews ®Surveys ®Interviews ®WHO Global Observatory ®WHO NCD Strategy ®Existence of appropriate policies and strategies ®Adoption of policies and strategies Table 2.1 | General health system characteristics: WHO UHC domain and relevant data sources CKD = chronic kidney disease, CVD = cardiovascular disease, GDP = gross domestic product, HD = hemodialysis, MD = medical doctor, NCD = non-communicable disease, WHO = World Health Organization 30 | Methods ISN Global Kidney Health Atlas | 2019 Table 2.2 | CKD-centric health system characteristics: WHO UHC domains and relevant data sources ACEi = angiotensin-converting enzyme inhibitor, ARB = angiotensin receptor blocker, AKI = acute kidney injury, CKD = chronic kidney disease, eGFR = estimated glomerular filtration rate, EPO = erythropoietin, GN = glomerulonephritis, GP = general practitioner, HD = hemodialysis, KRT = kidney replacement therapy, MBD = mineral bone disorder, MDT = multidisciplinary team, NCD = non-communicable disease, PD = peritoneal dialysis, WHO = World Health Organization Domain Indicators/metrics Data sources Essential elements Health service delivery ®Number of health facilities for general CKD care ®KRT services (e.g., number of health facilities offering HD, PD, transplantation services per country) ®Public vs. private ®Non-dialysis CKD care structure ®KRT care structure ®Literature reviews ®Surveys ®Interviews ®Accessibility of dialysis and kidney transplant units to all residents within a country ®Access to medications ®Reimbursement of treatment and care ®Kidney transplant waiting list ®Access to psycho-social counseling and support ®Existence, strength, role of patient organizations in each country Health workforce ®Number of nephrologists (per million population) ®Number of general physicians (per 10,000